<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0034-7418</journal-id>
<journal-title><![CDATA[Revista Colombiana de Ciencias Químico - Farmacéuticas]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. colomb. cienc. quim. farm.]]></abbrev-journal-title>
<issn>0034-7418</issn>
<publisher>
<publisher-name><![CDATA[Departamento de Farmácia, Facultad de Ciencias, Universidade Nacional da Colombia]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0034-74182022000301065</article-id>
<article-id pub-id-type="doi">10.15446/rcciquifa.v51n3.100189</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Premezclados como alternativa para el uso seguro de medicamentos intravenosos en escenarios de atención en salud]]></article-title>
<article-title xml:lang="en"><![CDATA[Premixed products, an alternative for safe intravenous medications use in health care settings]]></article-title>
<article-title xml:lang="pt"><![CDATA[As pré-misturas como alternativa para o uso seguro de drogas intravenosas em ambientes de saúde]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martínez Rojas]]></surname>
<given-names><![CDATA[Susan Paola]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ibatá Bernal]]></surname>
<given-names><![CDATA[Linda Margarita]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Taborda Restrepo]]></surname>
<given-names><![CDATA[Alejandra]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ariza]]></surname>
<given-names><![CDATA[Juan Guillermo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bonilla Arteaga]]></surname>
<given-names><![CDATA[Kelly]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,EpiThink Health Consulting  ]]></institution>
<addr-line><![CDATA[Bogotá D. C.]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2022</year>
</pub-date>
<volume>51</volume>
<numero>3</numero>
<fpage>1065</fpage>
<lpage>1082</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0034-74182022000301065&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0034-74182022000301065&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0034-74182022000301065&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Objetivo: presentar el panorama de errores de medicación, los recursos asociados a la preparación de medicamentos intravenosos y el uso de premezclados en la aten ción en salud.  Metodología: se realizaron búsquedas en diferentes bases de datos, sin límite de fecha o tipo de estudio. Adicionalmente se realizó un análisis para estimar los costos, validando con expertos los recursos en central de mezclas.  Resultados: los errores de medicación son un error médico común a nivel global. Los datos disponi bles son heterogéneos, pero sugieren que los errores de medicación pueden ser una causa considerable de morbilidad y mortalidad en ciertas poblaciones y contextos, con intervenciones adicionales, estancias hospitalarias prolongadas, mayores costos de atención y reducción en la probabilidad de que el tratamiento sea oportuno y eficaz. En medicinas intravenosas resultan escenarios de mayor gravedad y mayor nivel de costos. Los costos laborales anuales para una central de mezclas en Colombia se estiman entre 281,5 y 422,3 millones de pesos. La estandarización, como parte de los fármacos premezclados proporciona menor riesgo de contaminación, menor posibilidad de error en la preparación, menor incidencia de complicaciones rela cionadas con la terapia, disminución del desperdicio, mejora en la oportunidad de dispensación, optimización en el trabajo de los equipos de farmacia y reducción de costos asociados con este proceso.  Conclusiones: el uso de premezclados, como parte de un programa de reducción de errores de medicación, puede mejorar los indicadores de calidad en administración de medicamentos y garantizar un uso más seguro de la terapia intravenosa.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[SUMMARY  Objective: To present an overview of medication preparation and administration errors, the resources implied in the preparation of intravenous medications, and the use of premixed drugs in healthcare settings.  Methodology: We performed a litera ture review without limits by date or type of study. Additionally, analysis and vali dation by pharmaceutical experts were carried out to estimate the use of resources and related costs.  Results: The available heterogeneous data suggest that medication errors are a significant cause of morbidity and mortality in specific populations and settings. Error medications cause additional interventions, prolonged hospitalization, higher costs of care, and a reduction in the treatment probability of success. Errors involving intravenously administered drugs have more severe consequences and generate higher costs. Annual labor costs for centralized medication mixing in Colombia are estimated between $281.5 and $422.3 million. Premixed drugs decrease the risk of contamination, the possibility of error in the preparation, and the incidence of complications related to therapy. Also, its use is related to the reduc tion of waste, improvement in the timing of dispensing, optimizing the pharmacy team, and reducing costs associated with this process.  Conclusions: The use of premixes as part of a program to reduce medication errors can improve the quality indicators in drug administration and guarantee a safer use of intravenous therapy.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO  Objetivo: apresentar o panorama dos erros de medicação, os recursos associados ao preparo de medicamentos intravenosos e o uso de pré-misturas na assistência à saúde.  Metodologia: as buscas foram realizadas em diferentes bases de dados, sem limite de data ou tipo de estudo. Além disso, foi realizada uma análise para estimar os custos, validando com especialistas os recursos no centro de mistura.  Resultados: erros de medicação são um erro médico comum globalmente. Os dados disponíveis são heterogêneos, mas sugerem que os erros de medicação podem ser uma causa significativa de morbidade e mortalidade em certas populações e contextos, com intervenções adicionais, internações hospitalares mais longas, custos mais altos de atendimento e probabilidade reduzida de que o tratamento seja oportuno e eficaz. Nos medicamentos intravenosos, resultam cenários de maior gravidade e maior nível de custos. Os custos anuais de mão de obra para uma usina de mistura na Colômbia são estimados entre 281,5 e 422,3 milhões de pesos. A padronização, como parte dos medicamentos pré-misturados, proporciona menor risco de contaminação, menor possibilidade de erro no preparo, menor incidência de complicações relacionadas à terapêutica, redução de desperdícios, melhoria na oportunidade de dispensação, otimização no trabalho das equipes. da farmácia e redução dos custos associados a este processo.  Conclusões: o uso de pré-misturas, como parte de um programa de redução de erros de medicação, pode melhorar os indicadores de qualidade na admi nistração de medicamentos e garantir um uso mais seguro da terapia intravenosa.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Error de medicación]]></kwd>
<kwd lng="es"><![CDATA[farmacovigilancia]]></kwd>
<kwd lng="es"><![CDATA[medicamentos premezclados]]></kwd>
<kwd lng="en"><![CDATA[Medication error]]></kwd>
<kwd lng="en"><![CDATA[pharmacovigilance]]></kwd>
<kwd lng="en"><![CDATA[premixed medications]]></kwd>
<kwd lng="pt"><![CDATA[Erro de medicação]]></kwd>
<kwd lng="pt"><![CDATA[farmacovigilância]]></kwd>
<kwd lng="pt"><![CDATA[medicamentos pré-misturados]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="">
<collab>World Health Organization</collab>
<source><![CDATA[Medication Errors: Technical Series on Safer Pri mary Care]]></source>
<year>2016</year>
<page-range>32</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sutherland]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Canobbio]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Clarke]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Randall]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Skelland]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Weston]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Inci dence and prevalence of intravenous medication errors in the UK: a systematic review]]></article-title>
<source><![CDATA[Eur. J. Hosp. Pharm.]]></source>
<year>2020</year>
<volume>27</volume>
<page-range>3-8</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wittich]]></surname>
<given-names><![CDATA[C.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Burkle]]></surname>
<given-names><![CDATA[C. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Lanier]]></surname>
<given-names><![CDATA[W.L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medication errors: an overview for clinicians]]></article-title>
<source><![CDATA[Mayo Clin. Proc.]]></source>
<year>2014</year>
<volume>89</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1116-25</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<collab>NCC MERP</collab>
<source><![CDATA[About Medication Errors. What is a medication error?]]></source>
<year>2021</year>
<publisher-name><![CDATA[NCC MERP National Coordinating Council for Medication Error Reporting and Preven tion]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ferner]]></surname>
<given-names><![CDATA[R.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Aronson]]></surname>
<given-names><![CDATA[J.K.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clarification of terminology in medication errors]]></article-title>
<source><![CDATA[DrugSaf]]></source>
<year>2006</year>
<volume>29</volume>
<page-range>1011-22</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="">
<collab>Institute for Safe Medication Practices</collab>
<source><![CDATA[ISMP list of high-alert medications in acute care settings]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wolf]]></surname>
<given-names><![CDATA[Z.R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medication errors involving the intravenous administration route]]></article-title>
<source><![CDATA[J. Infus. Nurs.]]></source>
<year>2016</year>
<volume>39</volume>
<page-range>235-48</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moyen]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Camiré]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Stelfox]]></surname>
<given-names><![CDATA[H.T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical review: medication errors in critical care]]></article-title>
<source><![CDATA[Crit. Care]]></source>
<year>2008</year>
<volume>12</volume>
<page-range>208</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dean]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Barber]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[What is a prescribing error?]]></article-title>
<source><![CDATA[BMJ Dual. Saf.]]></source>
<year>2000</year>
<volume>9</volume>
<page-range>232-7</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Machado-Alba]]></surname>
<given-names><![CDATA[J.E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Errores de medicación identificados por un sistema de farmacovigilancia de instituciones hospitalarias en Colombia]]></article-title>
<source><![CDATA[Farm. Hosp.]]></source>
<year>2015</year>
<volume>39</volume>
<page-range>338-49</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[La OMS lanza una iniciativa mundial para reducir a la mitad los errores relacionados con la medicación en cinco años]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Makary]]></surname>
<given-names><![CDATA[M.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Daniel]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medical error, the third leading cause of death in the US]]></article-title>
<source><![CDATA[BMJ]]></source>
<year>2016</year>
<volume>353</volume>
<page-range>i2139</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nuckols]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Paddock]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Bower]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Rothschild]]></surname>
<given-names><![CDATA[J.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Fairbanks]]></surname>
<given-names><![CDATA[R.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Carlson]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Costs of intravenous adverse drug events in Academic and Nonacademic Intensive Care Units]]></article-title>
<source><![CDATA[Medical Care]]></source>
<year>2008</year>
<volume>46</volume>
<page-range>17-24</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lahue]]></surname>
<given-names><![CDATA[B.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Pyenson]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Iwasaki]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Blumen]]></surname>
<given-names><![CDATA[H.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Forray]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Rothschild]]></surname>
<given-names><![CDATA[J.M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[National burden of preventable adverse drug events associated with inpatient injectable medications: healthcare and medical professional liability costs]]></article-title>
<source><![CDATA[Am. Health Drug Benefits]]></source>
<year>2012</year>
<volume>5</volume>
<page-range>1-10</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Walsh]]></surname>
<given-names><![CDATA[E.K.]]></given-names>
</name>
<name>
<surname><![CDATA[Hansen]]></surname>
<given-names><![CDATA[C.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Sahm]]></surname>
<given-names><![CDATA[L.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Kearney]]></surname>
<given-names><![CDATA[P.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Doherty]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Bradley]]></surname>
<given-names><![CDATA[C.P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Economic impact of medication error: a systematic review]]></article-title>
<source><![CDATA[Pharmacoepidemiol. Drug Saf.]]></source>
<year>2017</year>
<volume>26</volume>
<page-range>481-97</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hedlund]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Beer]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Hoppe-Tichy]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Trbovich]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Systematic evidence review of rates and burden of harm of intravenous admixture drug preparation errors in healthcare settings]]></article-title>
<source><![CDATA[BMJ Open]]></source>
<year>2017</year>
<volume>7</volume>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ong]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
<name>
<surname><![CDATA[Subasyini]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medication errors in intravenous drug preparation and administration]]></article-title>
<source><![CDATA[Med. J. Malays.]]></source>
<year>2013</year>
<volume>68</volume>
<page-range>52-7</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cousins]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Sabatier]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Begue]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Schmitt]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Hoppe-Tichy]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medication errors in intravenous drug preparation and administration: a multicentre audit in the UK, Germany and France]]></article-title>
<source><![CDATA[BMJ Dual. Saf]]></source>
<year>2005</year>
<volume>14</volume>
<page-range>190-5</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Núñez-Nieto]]></surname>
<given-names><![CDATA[.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez-Ramos]]></surname>
<given-names><![CDATA[D.M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Los costos factor gerencial en la central de mezclas de una IPS-privada]]></source>
<year>2012</year>
<page-range>48</page-range><publisher-loc><![CDATA[Cartagena de Indias D. T. y C., Colombia ]]></publisher-loc>
<publisher-name><![CDATA[Universidad Tecnológica de Bolívar]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[H.E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Premixed intravenous admixtures: a positive development for hospital pharmacy]]></article-title>
<source><![CDATA[Am. J. Hosp. Pharm.]]></source>
<year>1983</year>
<volume>40</volume>
<page-range>1043-4</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Burghardt]]></surname>
<given-names><![CDATA[J.P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Further justification for use of premixed intravenous admixtures]]></article-title>
<source><![CDATA[Am. J. Hosp. Pharm.]]></source>
<year>1983</year>
<volume>40</volume>
<page-range>1472</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McDowell]]></surname>
<given-names><![CDATA[S.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Mt-Isa]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Ashby]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Ferner]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Where errors occur in the pre paration and administration of intravenous medicines: a systematic review and Bayesian analysis]]></article-title>
<source><![CDATA[BMJ Dual. Saf]]></source>
<year>2010</year>
<volume>19</volume>
<page-range>341-5</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hall]]></surname>
<given-names><![CDATA[J.W.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Safety, cost, and clinical considerations for the use of premixed paren teral nutrition]]></article-title>
<source><![CDATA[Nutr. Clin. Pract.]]></source>
<year>2015</year>
<volume>30</volume>
<page-range>325-30</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ruble]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impact safety, efficiency and the bottom line. Pharmacy]]></article-title>
<source><![CDATA[Purch. Prod.]]></source>
<year>2008</year>
<volume>5</volume>
<page-range>34-8</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Witte]]></surname>
<given-names><![CDATA[K.W.]]></given-names>
</name>
<name>
<surname><![CDATA[Eck]]></surname>
<given-names><![CDATA[T.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Vogel]]></surname>
<given-names><![CDATA[D.P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Decision analysis applied to the purchase of frozen premixed intravenous admixtures]]></article-title>
<source><![CDATA[Am. J. Hosp. Pharm.]]></source>
<year>1985</year>
<volume>42</volume>
<page-range>835-9</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Geberbauer]]></surname>
<given-names><![CDATA[C.W.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Purchasing premixed products]]></article-title>
<source><![CDATA[J. Healthc. Mater. Manage.]]></source>
<year>1988</year>
<volume>6</volume>
<page-range>44-5</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[A. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Penm]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Ivey]]></surname>
<given-names><![CDATA[M. F.]]></given-names>
</name>
<name>
<surname><![CDATA[Deng]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Commins]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Applying lean tech niques to reduce intravenous waste through premixed solutions and increasing production frequency]]></article-title>
<source><![CDATA[J. Healthc. Dual. JHQ]]></source>
<year>2018</year>
<volume>40</volume>
<page-range>2-8</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kirschenbaum]]></surname>
<given-names><![CDATA[B.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Cacace]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Anderson]]></surname>
<given-names><![CDATA[R.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Ackerman]]></surname>
<given-names><![CDATA[L.A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Personnel time and preparation costs for compounded versus premixed intravenous admixtures in three community hospitals]]></article-title>
<source><![CDATA[Am. J. Hosp. Pharm]]></source>
<year>1988</year>
<volume>45</volume>
<page-range>605-8</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Linden]]></surname>
<given-names><![CDATA[P. van der]]></given-names>
</name>
<name>
<surname><![CDATA[Douchamps]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Schmitt]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Forget]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ready-to-use injection preparations versus conventional reconstituted admixtures]]></article-title>
<source><![CDATA[Pharmacoeconomics]]></source>
<year>2002</year>
<volume>20</volume>
<page-range>529-36</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rosselli]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Rueda]]></surname>
<given-names><![CDATA[J.D.]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[M.D.]]></given-names>
</name>
<name>
<surname><![CDATA[Salcedo]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Economic evaluation of four drug administration systems in intensive care units in Colombia]]></article-title>
<source><![CDATA[Value Health Reg. Issues]]></source>
<year>2014</year>
<volume>5</volume>
<page-range>20-4</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="">
<collab>Joint Commission</collab>
<source><![CDATA[Sentinel Event Alert 11: High-Alert Medications and Patient Safety]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Partin]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Preventing medication errors: an IOM Report]]></article-title>
<source><![CDATA[Nurse Pract.]]></source>
<year>2006</year>
<volume>31</volume>
<numero>8</numero>
<issue>8</issue>
</nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="">
<collab>Institute for Safe Medication Practice (ISMP)</collab>
<source><![CDATA[Guidelines: Targeted Medication Safety Best Practices for Hospitals]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="">
<collab>ASHP, American Society of Health-System Pharmacists' IV Medication Sum mit</collab>
<source><![CDATA[Pharmacy Sterile Compounding Summit Summary of a Stakeholder Meeting]]></source>
<year></year>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
